ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) (ESLAW) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ESLAW ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM)

Watchlist

0.092
+0.000+0.11%

Close Nov 5 16:00 ET

0.092High0.092Low

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

News

10-K/A: Annual report (Amendment)
SECOct 28 17:05 ET · Announcements
10-K: Annual report
SECSep 27 13:19 ET · Announcements
Estrella Immunopharma Achieves Complete Response in First Patient Treated With CD19- Redirected ARTEMIS T-cells
BusinesswireSep 27 12:00 ET
Express News | Estrella Immunopharma Achieves Complete Response in First Patient Treated With Cd19- Redirected Artemis® T-Cells
ReutersSep 27 12:00 ET
Express News | Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member
ReutersAug 14 12:00 ET
10-Q: Quarterly report
SECMay 15 13:35 ET · Announcements

Comments

Moomoo AI

Oct 10, 2023 07:37

Estrella Immunopharma's cash burn issue is likely to demand shareholder attention. Possible solutions include borrowing or issuing new shares. The company should work to increase its operating revenue.

We're Hopeful That Estrella Immunopharma (NASDAQ:ESLA) Will Use Its Cash Wisely